• Mashup Score: 0

    HONOLULU — Women often have different presentations and symptoms of obstructive sleep apnea compared with men and are offered treatment less often, according to a speaker at the CHEST Annual Meeting.“At every step of the way, the woman or the female is at a disadvantage,” Carolyn D’Ambrosio, MS, MD, FCCP, associate professor of medicine and vice chief for fellowship

    Tweet Tweets with this article
    • 🔑 takeaways from a #CHEST2023 presentation: ➡️Women are less likely to be screened for or diagnosed with #OSA. ➡️These patients present with symptoms different from men, and some OSA #screening tools are more effective for women. Read more 👇 https://t.co/J1EdQpPcGJ

  • Mashup Score: 1

    Dr. Janice Kim speaks about why breast cancer is a complicated disease as well as the importance of clinical trials. Meet Dr. Martin Ma, who will be treating genitourinary cancers at the proton therapy center. Try some healthy and delicious foods this fall.

    Tweet Tweets with this article
    • #Breastcancer affects more than 200,000 people every year in the U.S. Because it is so varied, it can make #screening recommendations difficult. Dr. Janice Kim tells her patients to go with their intuition, "We are in tune with our bodies, we know best." https://t.co/UA6sUxfuO8 https://t.co/Oolw7SGiPK

  • Mashup Score: 1

    The response goes against a trend in guidelines aimed at helping health-care providers decide when to recommend different tests to patients—which national organizations have developed based on medical evidence. Cancer screening guidelines have started to factor in life expectancy because the risks from some cancer screenings may increase with age and because previous studies have shown that patients may need to live about 10 years to achieve the full benefits of detecting cancer early. “[M]any guidelines

    Tweet Tweets with this article
    • Attitudes Toward Life Expectancy as Cancer Screening Criteria https://t.co/t7OsSLy90I #cancer #screening #LifeExpectancy

  • Mashup Score: 1

    Bipartisan legislation that may help to eliminate financial barriers to prostate cancer screening was introduced in the U.S. Senate. Sponsored by Senators Cory Booker (D-NJ) and John Boozman (R-AR), the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease. If the legislation is passed, men at high risk of developing

    Tweet Tweets with this article
    • PSA Screening for HIM Act Introduced in Senate; Aims to Reduce Costs for Prostate Cancer Screening https://t.co/WthHsogqzY #pcsm #ProstateCancer #screening

  • Mashup Score: 0

    Use of real-time mass spectrometry breath analysis that has been enhanced by artificial intelligence is a potential COVID-19 screening method, according to a presentation at the European Respiratory Society International Congress.“We found that this method had good performance to detect COVID-19 with high-throughput, because … the test’s length is less than 1 minute,”

    Tweet Tweets with this article
    • Presented at the #ERSCongress: Use of real-time mass spectrometry breath 😮💨 analysis that has been enhanced by artificial intelligence 🧠 is a potential #COVID19 #screening method. @EuroRespSoc https://t.co/w6bIEH1E0g